IBSA - Institute Biochemical SA, founded by a group of Swiss biologists in 1945, has unique experience in research and innovative pharmaceutical technologies. It currently has operations in more than 90 countries. It has used its experience and expertise in the pharmaceutical industry to expand its business into dermatological medical devices based on hyaluronic acid. IBSA Derma differentiates itself in this market because it controls the entire product life cycle, from the bio-fermentation of the raw material to the ready-to-use final product in ampoules.

IBSA Derma's approach is aimed at counteracting the physiological disappearance of hyaluronic acid in the skin, resulting in the restoration of hydration, elasticity and tone. It works synergistically, combining deep hydration with mechanical skin lifting.

Scientific knowledge, continuous research, technological development and modern manufacturing processes make IBSA one of the leading pharmaceutical companies today in the production of hyaluronic acid for use in Aesthetic Medicine.

IBSA Derma's range of products based on ultra-pure hyaluronic acid are: Aliaxin, Profhilo, Profhilo Body, Viscoderm.

IBSA Poland sp. z o.o.
Al. Jana Pawła II 29,
00-867 Warsaw
e-mail: ibsaderma@ibsapoland.pl

ibsaderma.sklep.pl